Replies to post #122081 on Biotech Values

[DewDiligence]

FDA advisory panel endorses Shire’s Firazyr for acute HAE by 12-1 vote:

http://finance.yahoo.com/news/FDA-Advisory-Committee-prnews-3551456310.html?x=0&.v=1

The PDUFA date is 8/25/11.